Walmsley, who helped push GSK to focus more exclusively on specialty medicines and oncology, will be succeeded by commercial ...

GSK named Luke Miels to succeed Emma Walmsley as the British drugmaker’s CEO. - chris j ratcliffe/Reuters GSK said Emma ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

University of Maine researchers developed a new process to make HBL, a key ingredient in many medicines, from renewable ...

Nearly nine years ago, when Emma Walmsley was preparing to take over as CEO of GSK Plc, she wrote in her diary that Luke ...

The new, sustainable production method could help to address the high costs of crucial drugs like statins, antibiotics and ...

The rollout of antiretroviral therapy for HIV showed how global solidarity and smart policy can overcome barriers to new ...

Lupin's shares surged by 2.2% following tentative U.S. FDA approval for its generic HIV treatment, Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets. This positions Lupin to enter a ...

“The idea to process drugs in space isn’t new. Research showing that microgravity can impact crystallization has been done on ...

GSK CEO Emma Walmsley is stepping down next year after leading the company since 2017, aiming to pivot the U.K. firm into an innovative pharma company.

Biogen expands its drug delivery solutions by acquiring Alcyone Therapeutics, enhancing patient-centered therapies with the ...

Varda Space Industries is a winner of the 2025 Gizmodo Science Fair for successfully launching a first-of-its-kind in-orbit ...